CEO & Chairman of the Board, 10% Owner of Pain Therapeutics (ptie) Remi Barbier sells 21,403 shares of ptie on 09/02/2010 at an average price of $5.81 a share.

Pain Therapeutics has a market cap of $251.9 million; its shares were traded at around $5.91 with and P/S ratio of 12.3.

PTIE is in the portfolios of Jim Simons of Renaissance Technologies LLC.

CEO Recent Trades:

• Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 19,469 shares of PTIE stock on 08/09/2010 at the average price of 5.64. Remi Barbier owns at least 6,029,587 shares after this. The price of the stock has increased by 4.79% since.


• Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 22,391 shares of PTIE stock on 08/04/2010 at the average price of 5.71. Remi Barbier owns at least 6,049,056 shares after this. The price of the stock has increased by 3.5% since.


• Sell: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 27,243 shares of PTIE stock on 07/07/2010 at the average price of 5.35. Remi Barbier owns at least 6,071,447 shares after this. The price of the stock has increased by 10.47% since.


• Sell: CEO and Chairman of Board, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 06/03/2010 at the average price of 5.53. Remi Barbier owns at least 6,121,447 shares after this. The price of the stock has increased by 6.87% since.


• Sell: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 6,576 shares of PTIE stock on 05/06/2010 at the average price of 5.61. Remi Barbier owns at least 6,171,447 shares after this. The price of the stock has increased by 5.35% since.

Directors and Officers Recent Trades:

• Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 07/16/2010 at the average price of 5.54. Grant Schoenhard owns at least 48,157 shares after this. The price of the stock has increased by 6.68% since.


• Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 06/16/2010 at the average price of 5.45. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 8.44% since.


• Sell: Chief Scientific Officer Grant Schoenhard sold 10,979 shares of PTIE stock on 05/27/2010 at the average price of 5.74. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 2.96% since.


• Sell: Chief Scientific Officer Grant Schoenhard sold 2,486 shares of PTIE stock on 05/19/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 2.43% since.


• Sell: Chief Scientific Officer Grant Schoenhard sold 13,035 shares of PTIE stock on 05/18/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 2.43% since.